The Holistic prevention, management and treatment of Polycystic Ovarian Syndrome: The Best PCOs Diets for weight loss

By Kyle J. Norton Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                              Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to  continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).



                      The prevention and management 

Polycystic ovary syndrome (PCOS) is unpreventable in Western medicine. Early diagnosis and treatment  may reduce risk of its complications, including infertility, metabolic syndrome, obesity, diabetes, cardiovascular diseases, stroke, etc.

            In Weight Loss Perspective
                                                               
 Weight loss(733)(734) for obese patients is one of most vital factor to reduce PCOs symptoms(735)(737) and risk of PCOs complications(736)(737). Some researchers found that 5-10% of weight low will improve PCOs features(737) by 25%, including pregnancy(738). How can you lose weight and maintain healthy body for a healthy conception?

                                      
                       The Best PCOs Diet for weight loss

Most women with PCOs are likely overweight or obese according to BMI index. Most diet plans require the endurance and determination of the participants(750).

1. Complex carbohydrate, low protein and only unsaturated fat diet
This is the one which I have made for my diabetic friends, it works well for her. The plan not only helps to stabilize her blood sugar, but also maintain her weight within the normal range of BMI index. If you would like to try, please first consult with your doctor.
a) No Simple sugar
b) Only eat vegetables (prefer rainbow colors), nuts, seeds and limited intake of fruits containing high amount of sugar such as melon. Fruits only should be eaten as soon as after each meal.
b) Limited intake of protein to 1/3 of the daily amount. Meat must be lean (prefer chicken breast) and eat together with vegetables and fruits to further delay the release of sugar.
c) Only use unsaturated fat as toping. Stirring is allowed with occasional fried foods and others.
d) Drink at least 8 cups of pure water and milk ( prefer one cup of green tea and a cup of morning coffee with no sugar and a little bit milk). Since vegetables contain high amount of fiber, drinking more water can prevent constipation.
e) 1/4 table spoon of cinnamon each in the morning and evening. It is said that cinnamon stimulates the production of insulin(752) and regulates the blood sugar in the blood stream(753).
The diet works well for her in maintaining the healthy weight and stabilizing and lowering the blood sugar. Since she does not have PCOs and problem of infertility, it is for your benefit to check with your doctor before applying.

2. Low carbohydrate and high protein diet (Modified diet with a high-protein, low-glycemic load (30% of daily energy from protein plus low-glycemic-load foods)

This is a type of diet most recommended by dietitian for women with PCOs and wanted to get pregnant.
a) If you have symptoms of PCOs and absence of period, you must see your doctor before attempting any weight loss program.
b) If you have kidney problem, do not attempt this program
c) If you have symptoms of PCOs and irregular menstrual period, this diet plan is helpful
The low carbohydrate diet and high protein diet limits daily intake of amount of carbohydrate and encourages you to take a high amount of protein without restricting yourself to the amount of fat intake. With low levels of carbohydrate in the body, you body needs to burn its fat stores for energy, leading to weight loss(754) and lowering the levels of asting LDL-cholesterol, HDL-cholesterol, glucose, insulin, free fatty acid, and C-reactive protein concentrations(754). In theory, it works well for women with PCOs because by suppressing the levels of insulin(755)(756), The diet improves ovulation(755) and reduce the levels of testosterone(756). It is also recommended that you also engage in moderate exercise to improved the physical fitness level of healthy, pregnant as well(757)(758).

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months   
 
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O¹.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF¹, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R¹, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N¹, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB¹, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA¹, Arduc A², Tuna MM¹, Karakılıc E¹, Dagdelen I¹, Tutuncu Y¹, Berker D¹, Guler S¹.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO¹.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO¹, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J¹, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK¹, Katalenich B², Nagireddy P³, Chabbra P⁴, Kuhadiya N⁵, Fonseca V¹.(PubMed)
(14) Acne in hirsute women by Lumezi BG¹, Pupovci HL¹, Berisha VL¹, Goçi AU², Gerqari A³.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N¹, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H¹, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome. by Whigham LD¹, Butz DE², Dashti H³, Tonelli M³, Johnson LK¹, Cook ME², Porter WP⁴, Eghbalnia HR⁵, Markley JL⁶, Lindheim SR⁷, Schoeller DA⁸, Abbott DH⁹, Assadi-Porter FM¹⁰.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA¹, Azizia MM¹, Hardiman PJ².(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M¹, Kjaer SK², Jensen A¹, Munk C¹, Mellemkjaer L³.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E¹.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E¹, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(733) [Treatment of PCOS without IVF: weight loss, insulin-sensitizing agents].[Article in French] by Pugeat M¹.(PubMed)
(734) A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome by Jensterle M¹, Kravos NA¹, Pfeifer M¹, Kocjan T¹, Janez A¹.(PubMed)
(735) Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome by Esmaeilzadeh S, Andarieh MG¹, Ghadimi R, Delavar MA.(PubMed)
(736) Obesity and polycystic ovary syndrome by Naderpoor N¹, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(737)
(737) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H¹, Deeks A, Moran L.(PubMed)
(738) A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome by De Frène V¹, Vansteelandt S², T'Sjoen G³, Gerris J⁴, Somers S⁴, Vercruysse L⁴, De Sutter P⁴.(PubMed)
(739)  Carbohydrate(CDC)
(752) Chromium and polyphenols from cinnamon improve insulin sensitivity by Anderson RA¹.(PubMed)
(753) The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance by Kirkham S¹, Akilen R, Sharma S, Tsiami A.(PubMed)
(754) Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women by Noakes M¹, Keogh JB, Foster PR, Clifton PM.(PubMed)
(755) Diet and lifestyle in the prevention of ovulatory disorder infertility by Chavarro JE¹, Rich-Edwards JW, Rosner BA, Willett WC.(PubMed)
(756) Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study by Mehrabani HH¹, Salehpour S, Amiri Z, Farahani SJ, Meyer BJ, Tahbaz F.(PubMed)
(757) 30(+) years of exercise in pregnancy by Lotgering FK¹.(PubMed)
(758) Effect of a physical exercise program during pregnancy on uteroplacental and fetal blood flow and fetal growth: a randomized controlled trial by de Oliveria Melo AS¹, Silva JL, Tavares JS, Barros VO, Leite DF, Amorim MM.(PubMed)

A bright spark of summer any time of year recipe: Blue Cheese dressing

Posted By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.

Holiday collection by ATCO blue fame collection

A dressing as bold as this one needs, salad green that can stand up to its assertiveness. Try it on a mix of chopped arugula, radicchio, and endive the classic tricolor salad. Halve the recipe for small batch, suitable for 6 serving
1/2 cup ( 2 ounces) crumbled blue cheese
1/2 cup plain fat free yogurt
2 tsp. light mayonnaise
Combine all ingredients in a small bowl. Sore and covered in refrigerator for up to 4 days. Yield 3/4 cup. Serving size: 1 tsp.

Weight Loss the Easy Ways 
Andrea Albright Featured on Health and Fitness Jan. 2015
will Personally Coach You How to Get There The Easy Way

The Holistic prevention, management and treatment of Polycystic Ovarian Syndrome: The macro nutrients and Glycemic index

By Kyle J. Norton Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                                         Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to  continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).

                   In Weight Loss Perspective
                                                               


 Weight loss(733)(734) for obese patients is one of most vital factor to reduce PCOs symptoms(735)(737) and risk of PCOs complications(736)(737). Some researchers found that 5-10% of weight low will improve PCOs features(737) by 25%, including pregnancy(738). How can you lose weight and maintain healthy body for a healthy conception?

                                           The macro nutrients

1. Carbohydrate
Carbohydrate is simple sugar and complex sugar found abundantly in food, such as fruits, veggies, breads, cereals, and other grains.....with major function in production of energy for nourish cells, tissues and organs, through converting to blood sugar by digestive system(739).
a) Simple sugar
It contains food with no more than 2 simple sugar connected together. It can be release quickly into your bloodstream(740)(741).
b) Complex sugar
It contains food with long chain of simple sugar connected together, because most of them contain high amount of fiber. Foods will be digested slowly and sugars are released slowly into your bloodstream(740)(741).

2. Protein
Protein is important in building our body tissues. Its function is to carry out most of the reactions involved in metabolism and DNA replication, DNA repair, and transcription(742), therefore, it is important element in preparing for the growth of the bady once you are pregnant(743). Dr. Kramer MS1 and Kakuma R. at the McGill University said "Balanced energy/protein supplementation improves fetal growth and may reduce the risk of fetal and neonatal death. High-protein or balanced protein supplementation alone is not beneficial and may be harmful to the infant. Protein/energy restriction of pregnant women who are overweight or exhibit high weight gain is unlikely to be beneficial and may be harmful to the infant"(744).

3. Fat
Fat is essential for digestive system in absorbing several types of vitamins, maintaining healthy skin, hair, body temperature and healthy cells growth(746), stored as energy through its component of glycerol and expression and activity of the lipases of adipose tissue(745). Not all fats are bad(747)(748), by choosing more good fat and limited intake of the bad one, you are ensure yourself for a healthy pregnancy. Fats include saturated fat, transfat, monosaturated fat and polyunsaturated fat(749).


                                     The Glycemic index?
Glycemic index is a guide or table which rates all carbohydrates according to how fast they release glucose into the blood stream. The fastest release one has a high GI index. Preferences for only taking  foods with low GI index, if you want to lose weight(751)(750), but following low-GI dietary prescription is difficult(750)
                             

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months   
 
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O¹.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF¹, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R¹, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N¹, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB¹, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA¹, Arduc A², Tuna MM¹, Karakılıc E¹, Dagdelen I¹, Tutuncu Y¹, Berker D¹, Guler S¹.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO¹.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO¹, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J¹, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK¹, Katalenich B², Nagireddy P³, Chabbra P⁴, Kuhadiya N⁵, Fonseca V¹.(PubMed)
(14) Acne in hirsute women by Lumezi BG¹, Pupovci HL¹, Berisha VL¹, Goçi AU², Gerqari A³.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N¹, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H¹, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome. by Whigham LD¹, Butz DE², Dashti H³, Tonelli M³, Johnson LK¹, Cook ME², Porter WP⁴, Eghbalnia HR⁵, Markley JL⁶, Lindheim SR⁷, Schoeller DA⁸, Abbott DH⁹, Assadi-Porter FM¹⁰.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA¹, Azizia MM¹, Hardiman PJ².(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M¹, Kjaer SK², Jensen A¹, Munk C¹, Mellemkjaer L³.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E¹.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E¹, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(733) [Treatment of PCOS without IVF: weight loss, insulin-sensitizing agents].[Article in French] by Pugeat M¹.(PubMed)
(734) A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome by Jensterle M¹, Kravos NA¹, Pfeifer M¹, Kocjan T¹, Janez A¹.(PubMed)
(735) Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome by Esmaeilzadeh S, Andarieh MG¹, Ghadimi R, Delavar MA.(PubMed)
(736) Obesity and polycystic ovary syndrome by Naderpoor N¹, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(737)
(737) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H¹, Deeks A, Moran L.(PubMed)
(738) A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome by De Frène V¹, Vansteelandt S², T'Sjoen G³, Gerris J⁴, Somers S⁴, Vercruysse L⁴, De Sutter P⁴.(PubMed)
(739)  Carbohydrate(CDC)
(740) Effect of simple and complex carbohydrates on plasma non-esterified fatty acids, plasma-sugar, and plasma-insulin during oral carbohydrate tolerance tests by Swan DC, Davidson P, Albrink MJ.(PubMed)
(741) Carbohydrates and health: Not that simple...or that complex. Taking control of your blood sugar and insulin levels may pay off for your heart and overall health by [No authors listed](PubMed)
(742) Protein–DNA interaction(Wikepedia)
(743) Protein in your pregnancy diet(Babycenter)
(744) Energy and protein intake in pregnancy by Kramer MS¹, Kakuma R.(PubMed)

(745) Decreased lipases and fatty acid and glycerol transporter could explain reduced fat in diabetic morbidly obese by Ferrer R¹, Pardina E, Rossell J, Baena-Fustegueras JA, Lecube A, Balibrea JM, Caubet E, González O, Vilallonga R, Fort JM, Peinado-Onsurbe J.(PubMed)
(746) Fat(Wikipedia)
(747) All fats are not bad: a smart lesson to be learned by Ablin RJ, Jiang WG.(PubMed)
(748) Bad fats, good fats: new insights into diet and health.[No authors listed](PubMed)
(749)  Dietary fats in your pregnancy diet(BabyCenter)
(750) Potatoes, glycemic index, and weight loss in free-living individuals: practical implications by Randolph JM¹, Edirisinghe I, Masoni AM, Kappagoda T, Burton-Freeman B.(PubMed)
(751) No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet by Sloth B¹, Krog-Mikkelsen I, Flint A, Tetens I, Björck I, Vinoy S, Elmståhl H, Astrup A, Lang V, Raben A.(PubMed)

A bright spark of summer any time of year recipe: Asian Ginger-Carrot dressing

Posted By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.

Holiday collection by ATCO blue fame collection

Here's a healthier take on flavorful dressing found in salads restaurants across North America.
3 tsp. finely shredded carrot
3 tsp. mirin (sweet rice wine)
1/4 cup minced peeled fresh ginger
1/4 cup lower sodium soy sauce
2 tsp. rice vinegar
Combined all ingredients in a medium bowl, stirring with a whisk. Store, covered in refrigerator for up to 3 days. Yield about I cup. Serving size: 2 tsp.


Weight Loss the Easy Ways 
Andrea Albright Featured on Health and Fitness Jan. 2015
will Personally Coach You How to Get There The Easy Way

The Effects of Hormone Estrogen on Women Reproductive Organs

By Kyle J. Norton 
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.

Estrogen is a female sex hormone is defined as a group of compounds for its function in regulating in the estrous cycle of women after puberty.

1. Promote female reproductive system
Estrogen promotes female reproductive system beginning in the puberty by increasing pulsatile secretion of the hypothalamic gonadotropin releasing hormone (GnRH), which stimulates the release of gonadotropins and in turn gonadal activity, leading to the growth of breasts and other female characteristics. In a study of "Inducing puberty" by Delemarre EM, Felius B, Delemarre-van de Waal HA., posted in PubMed, researchers indicated that sex steroids will induce development of the secondary sex characteristics alone, while combined administration of gonadotropins and GnRH may induce gonadal development including fertility.

2. Accelerate metabolism
Estrogen enhances metabolism to allow the body of the women to grow, reproduce, maintain the structures and survival of the human species, adapt to the change of environments to sustain living, etc.. According to the study of "Differential roles of estrogen receptors α and β in control of B-cell maturation and selection" by Hill L, Jeganathan V, Chinnasamy P, Grimaldi C, Diamond B., posted in PubMed, researchers found that engagement of either estrogen receptor α or β can alter B-cell maturation, but only engagement of estrogen receptor α is a trigger for autoimmunity. Thus, maturation and selection are regulated differentially by estrogen. These observations have therapeutic implications.

3. Muscle mass, Abnormal fat distribution
According to the study of 64-week prospective cohort trial evaluated the effects of 20-mg oestradiol implants, replaced every 4 months, in healthy postmenopausal women aged 45-65 years. Of 20 implant and 14 control subjects who remained in the trial at 32 weeks, 13 implant and seven controls continued to 64 weeks, conducted by University of Sydney Royal North Shore Hospital, posted in PubMed, researchers concluded that The abdominal fat-to-lean soft tissue ratio decreased by 18% in implant subjects ( p<0.001), but did not change in controls ( p<0.05 implants versus controls). Neither group displayed significant changes in weight, fat or appendicular skeletal muscle mass. The 32-week data were consistent with these results. Hence, oestradiol implant therapy can reduce abdominal adiposity and could lower the risk of obesity-related metabolic disorders.

4. Increase bone density
Deficiency or reduced estrogen levels in post menopause women can lead to bone density loss.
According to the study of "A protective effect of Curcuma comosa Roxb. on bone loss in estrogen deficient mice" by Weerachayaphorn J, Chuncharunee A, Mahagita C, Lewchalermwongse B, Suksamrarn A, Piyachaturawat P., posted in PubMed, researchers suugested that suggest that C. comosa prevents bone loss induced by estrogen deficiency. Therefore, C. comosa would be a potential alternative treatment for prevention of postmenopausal osteoporosis.

5. Endometrial growthWomen's endomyrium undergoes certain change after puberty to adapt to the estrous cycle and pregnancy. According to the study conducted by Research laboratory at Kansai Medical University of 16 patients undergoing hysterectomy for benign reasons, in vitro, posted in PubMed, researchers found that the E(2) or OHT stimulates VEGF production and concurrently attenuates sVEGFR-1 production in ESCs. This consequential increase in VEGF:sVEGFR-1 ratio might enhance the biological effects of VEGF on the angiogenic environment in human endometrium.

6. Uterine growth

In the stage of estrous cycle, women uterus undergoes marked morphological, physiological and functional changes as a result of the levels of estrogen produced by the body. According to the study of "Characterisation of mouse interferon-induced transmembrane protein-1 gene expression in the mouse uterus during the oestrous cycle and pregnancy" by Park HJ, Kuk IS, Kim JH, Kim JH, Song SJ, Choi BC, Kim B, Kim NH, Song H., posted in PubMed, researchers concluded that Expression of Ifitm1 mRNA was higher in response to PMSG than other hormones investigated. These results suggest that Ifitm1 may be involved in uteri physiology, although the mechanisms involved in the regulation of this gene expression and function in the uterus remain unknown.

7. Vaginal lubrication
Vaginal lubrication is one of characteristic of hormone estrogen for women in per-manopause stage to moistens the vagina and to protect it especial during sexual intercourse. Insufficient lubrication or vaginal dryness in women can cause painful sexual intercourse disorder. According to the sudy of "Treatment options for female sexual arousal disorder: part II" by Feldhaus-Dahir M., posted in PubMed, researcher wrote that Female sexual arousal disorder (FSAD) occurs when a woman experiences distress due to the inability to attain or maintain adequate vaginal lubrication. Many treatments are still under investigation, and at this time, there are no FDA-approved medications available for the treatment of FSAD. Treatment options include "off-label" medications, vaginal estrogen, compounded preparations, and over-the-counter products.

8. Thicken the vaginal wall
As a result of level of estrogen, the vaginal wall is thickened to provide favorable condition for conception by moisturizing the vaginal and protecting the vaginal during sexual intercourse, In a study of The study included 89 patients undergoing vaginal surgery for urogynecological conditions, conducted by Mainz University Hospital, Dept. of Obstetrics and Gynecology,posted in PubMed, researchers found that menopausal women showed a higher amount of PR expression in vaginal tissue than premenopausal women. Women with no endocrine treatment showed a lower amount of ER β expression in vaginal tissue.

9. Etc.

Pregnancy Miracle
Reverse Infertility And Get Pregnant Naturally
Using Holistic Ancient Chinese Medicine


Back to Women Health http://kylejnorton.blogspot.ca/p/women-health.html
Back to Kyle J. Norton Home Page http://kylejnorton.blogspot.ca

A bright spark of summer any time of year recipe: Orange- Sesame dressing

Posted By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.

Holiday collection by ATCO blue fame collection

This bold dressing is best with salads stocked with big flavors such as those found in sliced fruit, chopped nuts, diced bell peppers and broccoli florets.

1/2 cup fresh orange juice ( about 2 large oranges)
1/3 cups of vinegar
2 tsp. sesame seeds
1 tsp. Chinese hot mustard
1 tsp. sugar
1/4 tsp. salt
1 garlic clove, minced
2 tsp. canola oil
1 tsp. dark sesame seed oil
Combine first 7 ingredients in a medium bowl. Slowly drizzle oils into juice mixture, stirring constantly with a whisk. Store, cover for up to 10 days. Yield 1/2. Serving size: 4 tsp.

Weight Loss the Easy Ways 
Andrea Albright Featured on Health and Fitness Jan. 2015
will Personally Coach You How to Get There The Easy Way

The Holistic prevention, management and treatment of Polycystic Ovarian Syndrome: Types of Conventional treatments

By Kyle J. Norton Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                                         Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to  continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).


               Types of Conventional treatments 
(Supplement pages)

There is no medical treatment for PCOs (induced weight loss for obese PCOs is primary objective). If pregnancy is not the concern, oral contraceptive medicine are prescribed. If pregnancy is a concern, the below have found to be most frequent treatment used conjunction with artificial insemination.
A. Fertility Drugs
1. Metformin
a) The effectiveness of metformin
Metformin, an oral anti-diabetic drug used to treat type II diabetes(652)(653) used widely in treating PCOs to induce weight loss in subjects with obesity,and infertility, improved insulin resistance(654)(655) by suppressing the production of endogenous glucose(656)(658) by the livcer(659)(661) and induced weight loss in obese patients(657)(658) through a reduction in calorie intake(657), as it makes insulin working more effective without changing the level of insulin in the body(659) by enhancing insulin-stimulated glucose disposal in skeletal muscle(659), which can lead to a lowering thyroid-stimulating hormone(660) and improved ovarian angiogenesis and follicular development(664) inhvolved PCOs pregancy(662)(663).

b) Side effects
i) Gastrointestinal upset(666)(667), especially for patient with disequilibrium of 2 genetic variations in OCT1(665), are mostly diarrhea(666)(667). Some patient may also experience nausea, vomiting, and decreased appetite(669).
ii) Reduce intestinal absorption of group B vitamins and folate in chronic therapy(668), may lead to accelerate the progression of vascular disease(668).
iii) Abdominal pain or cramps(669).
(iv) Metformin may have a growth-static effect on several cancers, including endometrial cancer, according to pre-clinical experiments(671)

2. Chomiphene (Clomid)
a) The effectiveness of chomiphene
It is considered as a fertility medication(670). The effectiveness of clomiphere is to induce ovulation(672) for natural conception for women with or without PCOs with luteal phase defect by stimulating the function of pituitary gland in series of hormone production(673), including LH, FSH. However, combination of metformin and clomiphene citrate may have some effects in improved pregnancy rates but not significantly improve the live birth rate over that of clomiphene citrate alone in women with polycystic ovary syndrome(674). Acupuncture, herbal medicine and clomiphene combination used for treatment of infertility on women with PCOs have shown to improve the pregnancy rate and reduce early abortion rate (675), according to Zhongguo Zhen Jiu. 2015 Feb;35(2):114-8.

b) Side effects
i) Abdominal pain and cramps(676).
ii) Breast tenderness(676)
iii) Ovaries edema(677)(678)
iv) Central nervous symptoms such as nervousness, sleeplessness, headaches, visual disturbances, vertigo(682), irritability, mood swings, feeling down(680)
v) Bloating(682) and hot flushes(681).
vi) Nausea, vomiting and dermatitis(683)
(vi) Women with BRCA mutation carriers may be at increased risk of invasive epithelial ovarian cancer (IEOC)(669).
(v) Risk of ovarian cysts(676)
(vi) Risk of ovarian cancer(684)(685)
(vii) Risks of melanoma and thyroid cancer(679).

3. Human Chorionic Gonadotropin (HcG)
a) The effectiveness of HCG
Human Chorionic Gonadotropin (HcG) is a hormone secreted by specialized cells called trophoblasts and later by the placenta following implantation(686)(687). The drug has been used conjunction of IVF for treatment of infertility to induce ovulation by stimulating the release of mature egg(688)(689), approximate 36 hour after taking it. HCG not only pinpoint the best time for sexual intercourse with success conception or assisting intrauterine insemination in egg retrieval(690)(691). The medicine also used for treatment to obese women with PCOs for weight loss(692)(693)(694) with controversy.

b) Side effects
Although side effects of HCG is not common, but some women may experience(697)
i) Headaches
ii) Irritability
iii) Restlessness, slight
iv) Water retention
v) Breast tenderness
vi) Depression
Other risks may include
(vii) Obstetrical complications, adverse perinatal outcomes, structural congenital abnormalities, chromosomal abnormalities, imprinting disorders, and childhood cancer(697)
(Vii) Ectopic pregnancy(689)
(viii) Blurred vision and scotomas(695).
(ix) Multiple pregnancy, miscarriage, ovarian hyperstimulation syndrome (OHSS)(696)

4. Human menopause gonadotropin(HMG)(Menotropin)
a) The effectiveness of HMG
HMG contains natural FSH and LH, is a purified form of urine of post menopausal women(699). By stimulating production of LH and FSH to right levels, the drug induces ovulation and develop mature follicles(700). The medication may be also used if chomiphere therapy and other medication have been failed to induce ovulation(701).

b) Side effects
i) Risk of multiple pregnancy, and spontaneous abortion(702)
ii) Ovarian enlargement (Caused by over stimulation)(705)
iii) Ovarian hyper stimulation syndrome (OHSS)(703)(704)
iv) Risk of miscarriage(704)
v) Risk of ovarian cancer(706)(707)
vi) Shortness of breath, dizziness, pelvic pain, nausea, and vomiting(708).


5. Dexamethasone
a) The effectiveness of dexamethasone
Dexamethasone is a synthetic member of the glucocorticoid class of steroid hormones and a prescribed medication for fertility to induce ovulation(709) for artificial insemination(710)by suppressing the androgen levels(711), resulting in increasing the chance of fertility(710).

b) Side effects
i) Risk of miscarriage(710)
i) Risk of bone growth at different developmental stages(713)
Other side effects, according to Rxlist(712) include

• sleep problems (insomnia), mood changes;
• acne, dry skin, thinning skin, bruising or discoloration;
• slow wound healing;
• increased sweating;
• headache, dizziness, spinning sensation;
• nausea, stomach pain, bloating;
• muscle weakness; or
• changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist).

6. Surgery
Surgery is not commonly performed. If necessary, PCOs infertility can be treated by either a laparoscopic surgery also is known as ovarian drilling(714)(715), the surgical procedure is not proven to be effective for women with PCOs infertility if used alone with potential surgical risks(714) or wedge resection(716), only to PCOs patients did not conceive with standard ovulation induction protocols(717). It is to your benefit to forgo this type of expensive treatment in favour of other such as IVF.

B. Oral Contraceptive
Only if pregnancy is not the concerns
1. The benefits of oral contrecptive
a. Reduce total testosterone levels and acne(718)
b. Improve lipid profiles, hsCRP levels, insulin resistance and hyperandrogenism(719)(720)
b. Regular menstrual cycle(720)
c. Lower androgen hormone levels(720) and lessen the amount of excess hair growth (also called “hirsutism”)(720)(721).
d. Decreased mentrual Cramps, or No Cramps(722)
e. Reduce risk of  colorectal and endometrial cancers(723), ovarian cancer(724), and ovarian cysts(725).

2. Risks and side effects
a) Risks
i) Risks of blood clots(728), stroke(728),  heart disease(726), cervical cancer(724) and breast cancer(727)(723)
ii) Hypertension(726) and increase heart rate(726) caused by thickening of blood in arteries.

b) Side effects
i) Bleeding and spotting(729)
ii) Weigh gain(730)(731)(732)(inconclusive result)


Remember the most effective long term treatment for PCOs can be done naturally at comfort at your own home.


Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months   
 
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O¹.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF¹, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R¹, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N¹, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB¹, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA¹, Arduc A², Tuna MM¹, Karakılıc E¹, Dagdelen I¹, Tutuncu Y¹, Berker D¹, Guler S¹.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO¹.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO¹, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J¹, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK¹, Katalenich B², Nagireddy P³, Chabbra P⁴, Kuhadiya N⁵, Fonseca V¹.(PubMed)
(14) Acne in hirsute women by Lumezi BG¹, Pupovci HL¹, Berisha VL¹, Goçi AU², Gerqari A³.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N¹, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H¹, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome. by Whigham LD¹, Butz DE², Dashti H³, Tonelli M³, Johnson LK¹, Cook ME², Porter WP⁴, Eghbalnia HR⁵, Markley JL⁶, Lindheim SR⁷, Schoeller DA⁸, Abbott DH⁹, Assadi-Porter FM¹⁰.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA¹, Azizia MM¹, Hardiman PJ².(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M¹, Kjaer SK², Jensen A¹, Munk C¹, Mellemkjaer L³.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E¹.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E¹, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(652) A 24-week, prospective, randomized, open-label, treat-to-target pilot study of obese type 2 diabetes patients with severe insulin resistance to assess the addition of exenatide on the efficacy of u-500 regular insulin plus metformin by Distiller LA¹, Nortje H², Wellmann H³, Amod A⁴, Lombard L⁵.(PubMed)
(653) One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target by Rosenstock J¹, Rodbard HW, Bain SC, D'Alessio D, Seufert J, Thomsen AB, Svendsen CB, DeVries JH; Liraglutide-Detemir Study Group.(PubMed)
(654) An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials by Sun J¹, Yuan Y¹, Cai R¹, Sun H¹, Zhou Y¹, Wang P¹, Huang R¹, Xia W¹, Wang S¹.(PubMed)
(655) Polycystic ovary syndrome (PCOS): metformin by Cahill DJ¹, O'Brien K.(PubMed)
(656) Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome by Kazerooni T¹, Dehghan-Kooshkghazi M.(PubMed)
(657) Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes by Lee A¹, Morley JE.(PubMed)
(658) The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes by Freemark M¹, Bursey D.(PubMed)
(659) Reducing insulin resistance with metformin: the evidence today by Giannarelli R¹, Aragona M, Coppelli A, Del Prato S.(PubMed)
(660) Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus by Fournier JP¹, Yin H¹, Yu OH¹, Azoulay L².(PubMed)
(661) Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats by Duca FA¹, Côté CD², Rasmussen BA², Zadeh-Tahmasebi M², Rutter GA³, Filippi BM¹, Lam TK⁴.(PubMed)
(662) Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study by Uysal S¹, Zeki Isik A², Eris S³, Yigit S⁴, Yalcin Y⁵, Ozun Ozbay P⁶.(PubMed)
(663) Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial by Morin-Papunen L¹, Rantala AS, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, Bloigu R, Puukka K, Ruokonen A, Tapanainen JS.(PubMed)
(664) Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model by Di Pietro M¹, Parborell F, Irusta G, Pascuali N, Bas D, Bianchi MS, Tesone M, Abramovich D.(PubMed)
(665) Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients by Tarasova L¹, Kalnina I, Geldnere K, Bumbure A, Ritenberga R, Nikitina-Zake L, Fridmanis D, Vaivade I, Pirags V, Klovins J.(PubMed)
(666) Ondansetron and metformin-induced gastrointestinal side effects by Hoffmann IS¹, Roa M, Torrico F, Cubeddu LX.(PubMed)
(667) Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome by Tso LO¹, Costello MF, Albuquerque LE, Andriolo RB, Macedo CR.(PubMed)
(668) Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects by Fisman EZ¹, Motro M, Tenenbaum A.(PubMed)
(669) Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trial by Ji L¹, Zinman B, Patel S, Ji J, Bailes Z, Thiemann S, Seck T.(PubMed)
(670) Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers by Perri T¹, Lifshitz D², Sadetzki S³, Oberman B⁴, Meirow D⁵, Ben-Baruch G², Friedman E⁶, Korach J².(PubMed)
(671) Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications by Sivalingam VN¹, Myers J², Nicholas S³, Balen AH³, Crosbie EJ⁴.(PubMed)
(672) The association between follicular size at the time of spontaneous rupture and pregnancy rates in clomiphene citrate treated PCOS patients in coit cycles by Portocarrero-Sanchez C¹, Gomes-Sobrinho DB, Nakagawa HM, Silva AA, Carvalho BR, Sarkis NT, Peraçoli JC, Cardoso MT.(PubMed)
(673) Clomid- Clomiphene Citrat(The reproductive medincine and surgery center of |Virginia. PLC)
(674) Metformin combined with clomiphene citrate may increase ovulation rates and pregnancy rates but does not significantly improve the live birth rate over that of clomiphene citrate alone.(I-A) Ovulation induction in polycystic ovary syndrome by Vause TD, Cheung AP, Sierra S, Claman P, Graham J, Guillemin JA, Lapensée L, Stewart S, Wong BC; Society of Obstetricians and Gynecologists of Canada.(PubMed)
(675) [Infertility in polycystic ovary syndrome treated with acupuncture and clomiphene: a randomized controlled trial].[Article in Chinese]by Jiang D, Zhang Y, Wu X, Wu S.(PubMed)
(676) Clomiphene therapy in epileptic women with menstrual disorders by Herzog AG1(PubMed)
(677) Massive ovarian edema in pregnancy after ovulation induction using clomiphene citrate by Kawaguchi R¹, Ueda S, Tsuji Y, Haruta S, Kanayama S, Yamada Y, Ooi H, Kobayashi H.(PubMed)
(678) Massive ovarian edema in a woman receiving clomiphene citrate. A case report by Patty JR¹, Galle PC, McRae MA.(PubMed)
(679) Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs by Althuis MD¹, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, Brinton LA.(PubMed)
(680) Psychological side-effects of clomiphene citrate and human menopausal gonadotrophin by Choi SH¹, Shapiro H, Robinson GE, Irvine J, Neuman J, Rosen B, Murphy J, Stewart D.(PubMed)
(681) Letrozole versus clomiphene for infertility in the polycystic ovary syndrome by Legro RS¹, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, Haisenleder DJ, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Trussell JC, Krawetz SA, Snyder P, Ohl D, Santoro N, Eisenberg E, Zhang H; NICHD Reproductive Medicine Network.(PubMed)
(682) Clomiphene citrate as a possible cause of a psychotic reaction during infertility treatment by Siedentopf F¹, Horstkamp B, Stief G, Kentenich H.(PubMed)
(683) [Efficacy and safety evaluation of acupuncture combined with auricular point sticking therapy in the treatment of polycystic ovary syndrome].[Article in Chinese]by Li N¹.(PubMed)
(684) Fertility drugs, reproductive strategies and ovarian cancer risk by Tomao F¹, Lo Russo G², Spinelli GP², Stati V², Prete AA², Prinzi N³, Sinjari M², Vici P⁴, Papa A², Chiotti MS², Benedetti Panici P¹, Tomao S².(PubMed)
(685) Ovarian cancer risk after the use of ovulation-stimulating drugs by Brinton LA¹, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL.(PubMed)
(686) New discoveries on the biology and detection of human chorionic gonadotropin by Laurence A Cole(PubMed)
(687) α-Fetoprotein and β-Human Chorionic Gonadotropin by John J. Gregory Jr, and Dr Jonathan L. Finlay(Spingerlink)
(688) human chorionic gonadotropin (HCG)(Drug.com)
(689) Ectopic pregnancy after in-vitro fertilization is characterized by delayed implantation but a normal increase of serum human chorionic gonadotrophin and its subunits by Korhonen J¹, Tiitinen A, Alfthan H, Ylöstalo P, Stenman UH.(PubMed)
(690) Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination by Mitwally MF¹, Abdel-Razeq S, Casper RF.(PubMed)
(691) A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS by Ramezanzadeh F¹, Nasiri R, Sarafraz Yazdi M, Baghrei M.(PubMed)
(692) Changes in chronic low back pain and cardiovascular risk factors using a homeopathic human chorionic gonadotropin-based weight loss program: a case report by Morningstar MW¹, Strauchman MN.(PubMed)
(693) An unfortunate resurgence of human chorionic gonadotropin use for weight loss by Lovejoy JC¹, Sasagawa M.(PubMed)
(694) Human chorionic gonadotropin is of no value in the management of obesity by C. L. Birmingham and K. C. Smith(PubMed)
(695) Ocular adverse effects of human chorionic gonadotropin by Lee M, Fried WI, Sharifi R.(PubMed)
(696) Synchronised approach for intrauterine insemination in subfertile couples by Cantineau AE¹, Janssen MJ, Cohlen BJ, Allersma T.(PubMed)
(697) HcG(Drug.com)
(698) Pregnancy outcomes after assisted reproductive technology.[Article in English, French] by Allen VM¹, Wilson RD, Cheung A; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC); Reproductive Endocrinology Infertility Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC).(PubMed)
(699) Compositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotropin). Identification of some of its major impurities by van de Weijer BH¹, Mulders JW, Bos ES, Verhaert PD, van den Hooven HW.(PubMed)
(700) Unexplained infertility and ovulatory induction with menopausal gonadotropins by Leanza V¹, Coco L, Grasso F, Leanza G, Zarbo G, Palumbo M.(PubMed)
(701) Ovulation induction with clomiphene citrate for infertile couple by Leanza V¹, Coco L, Grasso F, Leanza G, Zarbo G, Palumbo M.(PubMed)
(702) Patient-specific predictions of outcome after gonadotropin ovulation induction/intrauterine insemination by Goldman RH¹, Batsis M², Petrozza JC³, Souter I³.(PubMed)
(703) A case of severe ovarian hyperstimulation syndrome after gonadotropin therapy by Moneta E, Garcea N, Scirpa P, Mango D.(PubMed)
(704) [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].[Article in Chinese] by Ye H¹, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL.(PubMed)
(705) Hemodynamic state and the role of angiotensin II in ovarian hyperstimulation syndrome in the rabbit by Teruel MJ¹, Carbonell LF, Llanos MC, Parrilla JJ, Abad L, Hernandez I.(PubMed)
(706) Two cases of ovarian tumours in women who had undergone multiple ovarian stimulation attempts by Grimbizis G¹, Tarlatzis BC, Bontis J, Miliaras D, Lagos S, Pournaropoulos F, Mantalenakis S.(PubMed)
(707) Ovarian cancer after successful ovulation induction: a case report by Hull ME¹, Kriner M, Schneider E, Maiman M.(PubMed)
(708) Fertility drug: Gonadotropins(Baby center)
(709) Dexamethasone in unexplained infertility by Moradan S¹, Ghorbani R.(PubMed)
(710) [Steroid 21-hydroxylase deficiencies and female infertility: pathophysiology and management].

[Article in French] by Robin G¹, Decanter C², Baffet H³, Catteau-Jonard S², Dewailly D².(PubMed)

(711) The effect of dexamethasone on disruption of ovarian steroid levels and receptors in female rats by Illera JC¹, Silván G, Martínez MM, Blass A, Peña L.(PubMed) 

(712) Dexamethasone(Rxlist, the internet drug index)

(713) Dexamethasone use during pregnancy: potential adverse effects on embryonic skeletogenesis by Cheng X, Wang G, Lee KK, Yang X¹.(PubMed)

(714) Pregnancy outcomes after laparoscopic ovarian drilling in women with polycystic ovarian syndrome by Al-Ojaimi EH¹.(PubMed)

(715) Laparoscopic ovarian drilling: An alternative but not the ultimate in the management of polycystic ovary syndrome by Mitra S¹, Nayak PK¹, Agrawal S¹.(PubMed)

(716) Long-term clinical effects of ovarian wedge resection in polycystic ovarian syndrome by Hjortrup A, Kehlet H, Lockwood K, Hasner E.(PubMed)
(717) Ovarian wedge resection by minilaparatomy in infertile patients with polycystic ovarian syndrome: a new technique by Yildirim M¹, Noyan V, Bulent Tiras M, Yildiz A, Guner H.(PubMed)
(718) Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study by Di Carlo C¹, Gargano V, Sparice S, Tommaselli GA, Bifulco G, Nappi C.(PubMed)
(719) Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up by Yildizhan R¹, Gokce AI, Yildizhan B, Cim N.(PubMed)
(720) Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome by Kriplani A¹, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC.(PubMed)
(721) Ethinylestradiol/Chlormadinone acetate for use in dermatological disorders by Gómez Vázquez M¹, Navarra Amayuelas R, Lamarca M, Baquedano L, Romero Ruiz S, Vilar-Checa E, Iniesta MD.(PubMed)
(722) Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea by Witjes H¹, Creinin MD, Sundström-Poromaa I, Martin Nguyen A, Korver T.(PubMed)
(723) Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review by Gierisch JM¹, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER.(PubMed)
(724) [The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users].[Article in Serbian] by Veljković M¹, Veljković S.(PubMed)
(725) Oral contraceptive type and functional ovarian cysts by Lanes SF¹, Birmann B, Walker AM, Singer S.(PubMed)
(726) Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol by Grandi G¹, Xholli A¹, Napolitano A¹, Piacenti I¹, Bellafronte M¹, Cagnacci A².(PubMed)
(727) Correlation of age at oral contraceptive pill start with age at breast cancer diagnosis by Imkampe AK¹, Bates T.(PubMed)
(728) Cerebral vein thrombosis in women using short course oral contraceptive consumption by Sasannejad P¹, Mellat Ardekani A², Velayati A¹, Shoeibi A¹, Saeidi M¹, Foroughipour M¹,Azarpazhooh MR¹.(PubMed)
(729) Phase 3 study of desogestrel and ethinyl estradiol combined oral contraceptive for pregnancy prevention by Kroll R¹, Howard B, Hsieh J, Ricciotti N.(PubMed)
(730)Oral contraceptives use and weight gain in women with a Central European life-style by Lech MM¹, Ostrowska L.(PubMed)
(731) Weight and body composition changes during oral contraceptive use in obese and normal weight women by Mayeda ER¹, Torgal AH, Westhoff CL.(PubMed)
(732) An exploratory analysis of associations between eating disordered symptoms, perceived weight changes, and oral contraceptive discontinuation among young minority women by Hall KS¹, White KO, Rickert VI, Reame NK, Westhoff CL.(PubMed)